BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")
Recruiting · NCT03311776 · Observational (researchers observe without assigning treatment) · Lead sponsor: Inna Chen, MD
View the official record on ClinicalTrials.gov →What this trial is about
No validated biomarkers to identify PC at an early stage and to predict treatment outcomes in the individual patient exist. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
Who can take part
Age range
19 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age \> 18 years
- Histologically verified PC (ductal adenocarcinoma) or ampullary adenocarcinoma in a resected specimen; or histopathological confirmation of carcinoma in patients not undergoing surgery in the setting of clinical and radiological characteristics which, together with the pathology, are consistent with a diagnosis of PC independently of stage
Exclusion criteria
- None
Where it is running
1 location listed.
- Herlev & Gentofte Hospital - Herlev, Denmark